About: Birmingham Heartlands Development Corporation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Birmingham Heartlands Development Corporation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

UK government agency

Attributes	Values
rdf:type	Item
description	UK government agency (en)
rdfs:label	Birmingham Heartlands Development Corporation (en)
skos:prefLabel	Birmingham Heartlands Development Corporation (en)
name	Birmingham Heartlands Development Corporation (en)
Freebase ID	wds:Q4916714-411C6D7B-C51F-4418-B7DA-6B37FAEA464B
Freebase ID	/m/027kjhj
instance of	wds:Q4916714-AAC8E499-3B1B-49C9-83AE-22949899C5EE wds:Q4916714-f816e627-4a4f-cc0a-93a9-1c096442a238
instance of	development corporation defunct government institution
country	wds:Q4916714-6fce0cca-4788-ecc0-b575-2d4b8e0b9f6c
country	United Kingdom
dissolved, abolished or demolished date	wds:Q4916714-d1d79a3c-4cad-8675-48dc-c86cefe3d9f6
dissolved, abolished or demolished date	1998-04-03 00:00:00Z (xsd:dateTime)
inception	wds:Q4916714-41EBF3A6-77DA-49B3-B25B-882C87CF3848
inception	1992-01-01 00:00:00Z (xsd:dateTime)
headquarters location	wds:Q4916714-C769E9E8-1B6A-42FE-B542-6DEAA8FB7D1A
headquarters location	Birmingham
UK Parliament thesaurus ID	wds:Q4916714-B29E504C-4FCA-4390-8BCF-954F55D688DD
UK Parliament thesaurus ID	http://data.parliament.uk/terms/3882
UK Parliament thesaurus ID	3882
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q4916714 Birmingham Heartlands Development Corporation
is research site of	Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Firazyr® Patient Registry (Icatibant Outcome Survey - IOS) Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections Efficacy and Safety of Idelalisib (GS-1101; CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Multiple Myeloma Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma Strategic Timing of Antiretroviral Treatment A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments A Randomised Trial of Pulmonary Metastasectomy in Colorectal Cancer Speed of Increasing Milk Feeds Trial Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF) A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) Staphylococcus Aureus Bacteraemia in Adults Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma Efficacy and Safety/Tolerability of Grass MATA MPL Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax (GDC-0199) Versus Obinutuzumab + Chlorambucil in Participants With Chronic Lymphocytic Leukemia A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma A User Performance and System Use Evaluation of a New Blood Glucose Monitoring System ( BGMS) Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI (CONDI2/ERIC-PPCI) Actions & Insights Evaluating a Novel Diabetes Management Solution MUK Nine b: OPTIMUM Treatment Protocol GB001 in Adult Subjects With Moderate to Severe Asthma A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL Biomarker-based Exclusion of VAP for Improved Antibiotic Stewardship Packing of Perianal Abscess Cavities Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] A Study to Investigate the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Subcutaneous in Patients With Stage IV Non-Small Cell Lung Cancer Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure An Open Randomised Trial of the Arabin Pessary to Prevent Pre-term Birth in Twin Pregnancy A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software